Literature DB >> 9004129

Fine mapping of the dyskeratosis congenita locus in Xq28.

S W Knight1, T Vulliamy, G L Forni, D Oscier, P J Mason, I Dokal.   

Abstract

Dyskeratosis congenita (DC) is characterised by reticulate skin pigmentation, mucosal leucoplakia, and nail dystrophy. Bone marrow failure occurs in 50% of patients and is the principal cause of early mortality. In the majority of families the pattern of inheritance of DC is compatible with an X linked recessive trait. The locus for the X linked recessive form of DC has been linked to Xq28. We have now extended our earlier studies by investigating five families with additional Xq28 polymorphic markers; analysis of recombination events in these families has located the DC1 locus between GABRA3 and DXS1108, an interval of approximately 4 Mb.

Entities:  

Mesh:

Year:  1996        PMID: 9004129      PMCID: PMC1050808          DOI: 10.1136/jmg.33.12.993

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  22 in total

1.  Dyskeratosis congenita fibroblasts are abnormal and have unbalanced chromosomal rearrangements.

Authors:  I Dokal; J Bungey; P Williamson; D Oscier; J Hows; L Luzzatto
Journal:  Blood       Date:  1992-12-15       Impact factor: 22.113

2.  Identification of a second pseudoautosomal region near the Xq and Yq telomeres.

Authors:  D Freije; C Helms; M S Watson; H Donis-Keller
Journal:  Science       Date:  1992-12-11       Impact factor: 47.728

3.  Rapid PCR analysis of the St14 (DXS52) VNTR.

Authors:  B Richards; R Heilig; I Oberlé; L Storjohann; G T Horn
Journal:  Nucleic Acids Res       Date:  1991-04-25       Impact factor: 16.971

4.  Dinucleotide repeat polymorphism in the human X-linked GABAA receptor alpha 3-subunit gene.

Authors:  A A Hicks; K J Johnson; E A Barnard; M G Darlison
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

5.  DNA in heritable disease.

Authors:  B C Sykes
Journal:  Lancet       Date:  1983-10-01       Impact factor: 79.321

6.  Mutational analysis of the biglycan gene excludes it as a candidate for X-linked dominant chondrodysplasia punctata, dyskeratosis congenita, and incontinentia pigmenti.

Authors:  S Das; A Metzenberg; G S Pai; J Gitschier
Journal:  Am J Hum Genet       Date:  1994-05       Impact factor: 11.025

7.  Molecular evidence that the p55 gene is not responsible for either of two Xq28-linked disorders: Emery-Dreifuss muscular dystrophy and dyskeratosis congenita.

Authors:  A B Metzenberg; Y Pan; S Das; G S Pai; J Gitschier
Journal:  Am J Hum Genet       Date:  1994-05       Impact factor: 11.025

8.  Dinucleotide repeat polymorphism close to IDS gene in Xq27.3-q28 (DXS1113).

Authors:  C Weber; C Oudet; S Johnson; G Pilia; D Schlessinger; A Hanauer
Journal:  Hum Mol Genet       Date:  1993-05       Impact factor: 6.150

9.  Dyskeratosis congenita: three additional families show linkage to a locus in Xq28.

Authors:  R Arngrimsson; I Dokal; L Luzzatto; J M Connor
Journal:  J Med Genet       Date:  1993-07       Impact factor: 6.318

10.  X-linked dyskeratosis congenita with pancytopenia.

Authors:  A Gutman; A Frumkin; A Adam; N Bloch-Shtacher; L A Rozenszajn
Journal:  Arch Dermatol       Date:  1978-11
View more
  6 in total

1.  1.4 Mb candidate gene region for X linked dyskeratosis congenita defined by combined haplotype and X chromosome inactivation analysis.

Authors:  S W Knight; T J Vulliamy; N S Heiss; G Matthijs; K Devriendt; J M Connor; M D'Urso; A Poustka; P J Mason; I Dokal
Journal:  J Med Genet       Date:  1998-12       Impact factor: 6.318

2.  Nonrandom X-chromosome inactivation in hemopoietic cells from carriers of dyskeratosis congenita.

Authors:  A M Ferraris; G L Forni; R Mangerini; G F Gaetani
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

3.  Genetic and environmental factors influencing human diseases with telomere dysfunction.

Authors:  Hinh Ly
Journal:  Int J Clin Exp Med       Date:  2009-05-31

4.  Dyskeratosis congenita: the first NIH clinical research workshop.

Authors:  Sharon A Savage; Inderjeet Dokal; Mary Armanios; Geraldine Aubert; Edward W Cowen; Demetrio L Domingo; Neelam Giri; Mark H Greene; Paul J Orchard; Jakub Tolar; Ekaterini Tsilou; Carter Van Waes; Judy M Y Wong; Neal S Young; Blanche P Alter
Journal:  Pediatr Blood Cancer       Date:  2009-09       Impact factor: 3.167

Review 5.  Beginning at the ends: telomeres and human disease.

Authors:  Sharon A Savage
Journal:  F1000Res       Date:  2018-05-01

Review 6.  Telomerase RNA processing: Implications for human health and disease.

Authors:  Neha Nagpal; Suneet Agarwal
Journal:  Stem Cells       Date:  2020-09-01       Impact factor: 6.277

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.